Welcome to the Giehm Lab
Welcome to our world of genetic engineering and molecular genetics. We study genome editing and gene transfer technologies for transgenesis and development of genetic therapies. Our mission is to innovate viral and nonviral gene delivery technologies for development of new gene correction and therapy concepts.
We are currently studying molecular disease mechanisms and new ways of delivering the goods for genome editing. We have established genome-wide screening technologies using CRISPR and are adapting forward genetic screens in studies of cancer drug tolerance as well as gene regulation in cancer and innate immunity.
Jacob Giehm Mikkelsen, Head of Lab
Recent news from the lab:
Skippers work on the use of lentiviral particles for delivery of piggyBac transposase protein is now out in Molecular Therapy Nucleic Acids